Clinical Trials Directory

Trials / Completed

CompletedNCT00212732

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
750 (planned)
Sponsor
Ono Pharmaceutical Co., Ltd. · Industry
Sex
All
Age
20 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to evaluate the efficacy and safety of ONO-8025 (KRP-197) in patients with overactive bladder.

Conditions

Interventions

TypeNameDescription
DRUGONO-8025 (KRP-197)

Timeline

Start date
2003-10-01
Primary completion
2006-04-01
First posted
2005-09-21
Last updated
2012-10-11

Source: ClinicalTrials.gov record NCT00212732. Inclusion in this directory is not an endorsement.

Controlled Study of ONO-8025 (KRP-197) in Patients With Overactive Bladder in Japan (NCT00212732) · Clinical Trials Directory